Dihydromyricetin suppresses inflammatory injury in microglial cells to improve neurological behaviors of Alzheimer's disease mice via the TLR4/MD2 signal.

Hongyan Pei,Chenyang Han,Jinhao Bi,Zhongmei He,Li Guo
DOI: https://doi.org/10.1016/j.intimp.2023.110037
IF: 5.714
2023-01-01
International Immunopharmacology
Abstract:DHM targeted MD2 to suppress the formation of TLR4 protein complex, thereby suppressing inflammatory injury in microglial cells and improving the cognition in AD mice.
What problem does this paper attempt to address?